N/A N=30 Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury
Acute Kidney Injury
Primary: Maximum and Minimum Diameters of the Inferior Vena Cava in Patients With Acute Kidney Injury — 1.8; 1.2 cm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=96 The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
Acute Kidney Failure
Primary: Progression to Stage 3 AKI — 23 Participants
Phase 4 N=57 Kidney Damage in Patients With Moderate Fall in eGFR
Coronary Artery Stenosis
Primary: Impact on the Trajectory of Serum and Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) Following Administration — -27.76; -11.11; -11.84; -8.23 ng/mL
N/A N=4,003 Personalized Recommendations for Acute Kidney Injury (AKI) Care
Acute Kidney Injury
Primary: Composite Outcome Showing the Percentage of Participants With Any One of the Following: Progression of AKI, Inpatient Dialysis, or Inpatient Death — 369; 395…
N/A N=73 Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS
Sepsis
Primary: Delta Curve Between Calculated GFR and GFR Measured by Iohexol at Baseline — 91.5; 88.3; 93.6; 90.0 ml/min/1.73m2 — p=<0.05
Phase 2 N=26 Lowering Serum Uric Acid to Prevent Acute Kidney Injury
Hyperuricemia
Primary: Number of Patients With Acute Kidney Injury (AKI). — 13; 13 Participants
N/A N=77 Protocol to Assess the Severity of Acute Kidney Injury
Acute Kidney Failure
Primary: Urine Volume — 89; 329; 96; 392 ml
N/A N=5,060 Drug-Targeted Alerts for Acute Kidney Injury
Acute Kidney Injury
Primary: Percentage of Patients With Progression of AKI OR Dialysis OR Death — 639; 585 Participants
N/A N=10,252 IMPROVE AKI Cluster-Randomized Trial
Acute Kidney Injury
Primary: Acute Kidney Injury — 110; 190; 122; 88 Participants
N/A N=1,001 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Acute Kidney Injury
Primary: The Efficacy of the Triage Neutraphil-Gelatinase Associated Lipocalin (NGAL) Test as an Aid in the Diagnosis of Acute Kidney Injury (AKI) in an All-comers ICU Setting…
N/A N=64,882 Epidemiology of Acute Kidney Injury in England - 1998 to 2013
Acute Kidney Injury
Primary: Secular Trends in the Mortality After Acute Kidney Injury From 1998 to 2013 — 1296; 3763; 19793 participants
N/A N=18 Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)
Complication of Extracorporeal Circulation · Renal Impairment
Primary: Renal Blood Flow (RBF) — 554; 524; 564; 558 ml per minute per 1.73 m2 body surface — p=0.638
Phase 2 N=92 Prevention of Acute Kidney Injury in Cardiac Surgery Patients
Kidney Injury
Primary: Number of Participants With Acute Kidney Injury — 20; 14 participants
N/A N=1,001 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study
Acute Decompensated Heart Failure · Acute Kidney Injury
Primary: Evaluating the Efficacy of the Triage NGAL Test as an Aid to Diagnosis of Acute Kidney Injury (AKI) in Patients Admitted to the Hospital With Symptoms of Acute Heart…
N/A N=35 NIRS Monitoring to Detect AKI in Preterm Infants
Acute Kidney Injury · Premature Infant
Primary: Renal NIRS Tissue Oxygenation Differential — 60; 32.4; 62.5; 44.4 percentage saturation — p=<0.001
N/A N=42 Acute Renal Injury During High Intensity Training
Acute Kidney Injury · Exercise
Primary: Change in Concentration of Proenkephalin-A From Baseline to 4 Time-points Surrounding the Workout — 1.65; 3.69; 2.50; 2.13 pmol/L
N/A N=50 A Study of Acute Kidney Injury in Care Transitions
Acute Kidney Injury
Primary: Number of Subjects to Complete the ACT Program — 22 Participants
N/A N=15,724 Intensive Monitoring of Renal Function
Intensive Monitoring of Renal Function · Acute Kidney Injury
Primary: Detection of Acute Kidney Injury (AKI) — 1.22; 1.22; 1.11; 1.11 Odds Ratio
Phase 4 N=66 Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
Dissection of Thoracic Aorta
Primary: Incidence of Acute Kidney Injury Based on RIFLE Criteria
N/A N=108 Trial Assessing Renal Damage During Ureteroscopy
Nephrolithiasis
Primary: Change in Kidney Injury Molecule-1 (KIM-1) — 0.01077; 0.01228; 0.0246; 0.02413 ng/ml
N/A N=2,393 An Electronic Alert System for In-Hospital Acute Kidney Injury
Acute Kidney Injury
Primary: Dialysis Within 7 Days — 87; 70 participants
Phase 4 N=49 Kidney Damage in Patients With Normal eGFR
Coronary Artery Stenosis
Primary: Impact on the Trajectory of Serum and Urinary NGAL Following the Administration of Non-ionic Low Osmolar Contrast Media. — -14.84; -17.71; -9.98; -2.37 ng/mL
N/A N=144 Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery
Acute Kidney Injury
Primary: Acute Kidney Injury Measured by Kidney Diseases: Improving Global Outcomes (KDIGO) AKI Serum Creatinine Criteria — 43; 36 participants
Phase 4 N=30 Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
Renal Transplant Rejection · Immunosuppression
Primary: Cytokines Evaluation — 380; 893; 763; 147 MFI — p=<0.05
N/A N=134 Assessment of Urinary NGAL to Predict AKI in Children Receiving Multiple Nephrotoxic Medications
Acute Kidney Injury · Nephrotoxicity
Primary: Number of Patients With Nephrotoxic Medication Associated AKI Detected by Urinary NGAL — 3; 6; 24; 80 Participants
N/A N=245 Tissue Oxygenation During Treatment of Infant Congenital Heart Defects
Acute Kidney Injury · Hypoxia-Ischemia, Brain · Mesenteric Ischemia
Primary: Number of Participants With Acute Kidney Injury — 18; 57 Participants
Phase 2 N=150 Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury
Critically Ill · Acute Kidney Injury
Primary: Death Within 7 Days — 4; 9; 6 Participants — p=0.52
N/A N=40 Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
Kidney Failure, Acute · Acute Kidney Insufficiency
Primary: Development of Post-operative Acute Kidney Injury — 10; 7 participants meeting primary oputcome
Phase 2 N=30 Fluid Chloride and AKI in Cardiopulmonary Bypass
Acute Kidney Injury
Primary: Change in [TIMP2]*[IGFBP7] Biomarker — 0.015; 0.009 (ng/mL)^2/1000
Phase 4 N=267 Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI
Acute Kidney Injury
Primary: Renal Function — .46; .75; 4.26; 2.80 mL/min/1.73m^2 — p=>0.05